NCT01428895 2026-03-06
Femoral Bone Metastases
University Health Network, Toronto
Phase NA Active not recruiting
Clinical Trials
35 trialsNCT05039632 2026-02-06
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05061342 2026-01-27
TQ-BIRD
The University of Hong Kong-Shenzhen Hospital
Recruiting
NCT02560636 2026-01-06
PLUMMB
Royal Marsden NHS Foundation Trust
Phase 1 Active not recruiting
NCT07269899 2025-12-08
Reboot-107
Sun Yat-sen University
Phase 1 Recruiting
NCT07018570 2025-08-26
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
National Cancer Center Hospital East
Phase 2 Recruiting
NCT07142200 2025-08-26
DECIDING
RenJi Hospital
Phase 2 Not yet recruiting
NCT06306924 2025-05-01
UNC Metastatic Cancer Radiation Therapy Registry
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT02344121 2025-04-23
Intra- and Inter-fraction Changes in Radiation Therapy
Medical College of Wisconsin
Recruiting
NCT05301881 2025-02-05
COSMO
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT04375891 2025-02-04
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
Baptist Health South Florida
Phase NA Active not recruiting
NCT04376502 2025-01-03
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Baptist Health South Florida
Phase NA Terminated
NCT06112041 2023-11-01
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
Second Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT06047860 2023-09-21
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT00176267 2023-06-01
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
University of Kentucky
Phase 2 Completed
NCT00176254 2023-05-16
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
University of Kentucky
Phase 2 Completed
NCT05790447 2023-03-30
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05755009 2023-03-07
ST-CR01
Jiangxi Provincial Cancer Hospital
Phase NA Unknown
NCT03453892 2023-02-16
ST-ICI
University of Erlangen-Nürnberg Medical School
Completed
NCT05144100 2021-12-03
SCOPE
Tata Memorial Centre
Phase 2/3 Not yet recruiting
NCT05115500 2021-11-10
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT02303990 2021-05-12
RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00426504 2020-07-30
Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer
Ottawa Hospital Research Institute
Phase NA Completed
NCT03677531 2020-05-04
Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy
OHSU Knight Cancer Institute
Phase 1 Completed
NCT02368106 2019-09-12
GCC 1490
University of Maryland, Baltimore
Withdrawn
NCT03543696 2019-07-23
OLIGO
Fundacao Champalimaud
Phase NA Unknown
NCT00389727 2019-07-15
Simultaneous Integrated Boost (SIB)- IMRT
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Completed
NCT00463060 2018-07-18
Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT00226239 2017-07-11
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer
University of Pittsburgh
Phase 2 Completed
NCT01676428 2016-11-01
FASTRACK
Peter MacCallum Cancer Centre, Australia
Phase NA Completed
NCT02674646 2016-02-04
ROSETTA
Technical University of Munich
Phase 2 Unknown
NCT01232374 2015-08-20
Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT01427322 2015-07-08
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
Virginia Commonwealth University
Phase EARLY_PHASE1 Terminated
NCT00707278 2014-10-31
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
University of Utah
Phase 1 Completed
NCT00751543 2010-06-29
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
National Taiwan University Hospital
Phase NA Unknown